Skip to main navigation Skip to search Skip to main content

Stimulation of microsomal drug oxidation in liver and kidney of rats treated with the oncolytic agent cis-dichlorodiammineplatinum-II

Research output: Contribution to journalArticlepeer-review

Abstract

In vitro drug metabolism from liver and kidney of rats was studied for up to 12 days following a single intraperitoneal injection of the antineoplastic drug cisplatinum. At 3, 5, and 8 days posttreatment, hepatic cytochrome P-450 dependent enzyme activity was increased 20–45%, but levels of cytochromes P-450 and b5 were unaltered. Hepatic in vitro stimulated thiobarbituric acid reactive (TBAR) substances were increased at all times, with a maximum of 20 times normal on day 5. Renal aniline hydroxylase activity was elevated 25–95% throughout the first 8 days. Renal in vitro stimulated TBAR substances were not significantly altered. In vitro addition of cisPt to control microsomes resulted in no consistent, dose-related changes in substrate metabolism.

Original languageEnglish (US)
Pages (from-to)46-53
Number of pages8
JournalPharmacology
Volume26
Issue number1
DOIs
StatePublished - 1983
Externally publishedYes

Keywords

  • Cisplatinum
  • Hepatic drug metabolism
  • In vitro drug metabolism
  • Microsomal drug metabolism
  • Renal drug metabolism

ASJC Scopus subject areas

  • Pharmacology

Fingerprint

Dive into the research topics of 'Stimulation of microsomal drug oxidation in liver and kidney of rats treated with the oncolytic agent cis-dichlorodiammineplatinum-II'. Together they form a unique fingerprint.

Cite this